"Neuromod secures €10m to expand tinnitus treatment device’s availability" was originally created and published by Medical ...
Neuromod Devices announced today that it closed an equity financing round worth proceeds of about $10.9 million (€10 million) ...
Dublin-based Neuromod has raised €10.5m and plans to further fuel Lenire's commercialisation in Europe and reach US veterans.
Neuromod Devices Ltd. raised €10 million (US$10.9 million) in financing to expand the reach of Lenire, which treats tinnitus.
Irish medtech group Neuromod Devices has raised €10 million equity financing to expand the availability of its tinnitus ...
Irish medtech company Neuromod has raised €10m in equity financing to expand the production of Lenire – a device that helps ...
Dublin-based company has developed an FDA-approved device called Lenire that is for use with patients suffering from tinnitus ...
The financing was oversubscribed and was led by existing investors Fountain Healthcare Partners and Panakès Partners, backing Neuromod's mission to advance tinnitus care for patients globally.